• Illucidx

RT-LAMP FDA EUA Submission June 2020

Illucidx submitted COVID-19 Dx RT-LAMP to the FDA for Emergency use Authorization in June of 2020


25 views0 comments

Headquartered in Calgary, Alberta, Canada we hope to enable broad access to ultra-sensitive diagnostics tools for settings across the globe. Our first priority is, and will always remain, to improve clinical outcomes.

Please email for direct number


3655 36 St NW 

Calgary, AB T2L 1Y8


  • LinkedIn

© 2020 Illucidx Inc Previously Elucidx Inc.